Condition

Peripheral T-Cell Lymphoma, Not Otherwise Specified clinical trials and research

• 8Clinical trials
• 4Countries

Newest Peripheral T-Cell Lymphoma, Not Otherwise Specified clinical trials

All recruiting trials (8)

• Duvelisib maintenance after first-line therapy for peripheral T-cell lymphomas

  This phase II study tests whether taking duvelisib pills after initial treatment helps keep follicular helper T-cell and other peripheral T-cell lymphomas from coming back in adults who have responded to therapy and did not have a transplant.

  Recruiting Phase 2 City of Hope Medical Center · Duarte, California · NCT07293403

• Ruxolitinib with CHOP for untreated nodal TFH cell lymphoma

  This phase 1 trial tests whether adding ruxolitinib to CHOP chemotherapy is safe and tolerable in adults with untreated nodal TFH cell lymphoma.

  Recruiting Phase 1 City of Hope Medical Center · Duarte, California · NCT07278856

• High-dose chemotherapy with autologous stem cell transplant versus observation for peripheral T‑cell lymphoma in complete remission

  This trial tests whether giving high‑dose chemotherapy followed by the patient's own stem cell transplant helps adults with peripheral T‑cell lymphoma who are in complete remission stay cancer‑free longer than observation alone.

  Recruiting at 142 sites Phase 3 Eastern Cooperative Oncology Group · Birmingham, Alabama and 164 other locations · NCT06724237

• Q702 to treat blood cancers

  This Phase 1 trial will test whether the oral drug Q702 is safe, tolerable, and what dose works best for adults with certain blood cancers who have failed or are not eligible for standard treatments.

  Recruiting at 2 sites Phase 1 Mayo Clinic · Scottsdale, Arizona and 1 other locations · NCT06712810

• Comparing soquelitinib to standard treatments for certain types of relapsed T-cell lymphoma

  This study is testing if a new pill called soquelitinib can work better than regular treatments for people with certain types of relapsed T-cell lymphoma.

  Recruiting at 37 sites Phase 3 Corvus Pharmaceuticals, Inc. · Duarte, California and 36 other locations · NCT06561048

• Using a modified virus to treat patients with T-cell lymphoma

  This study is testing a modified virus combined with immunotherapy to see if it can safely treat patients with different types of T-cell lymphoma.

  Recruiting at 2 sites Phase 1 Mayo Clinic · Scottsdale, Arizona and 1 other locations · NCT06508463

• Registry for individuals with T-cell lymphoma

  This study is gathering information from people with T-cell lymphoma to help researchers learn more about the disease and improve treatments.

  Recruiting at 6 sites Memorial Sloan Kettering Cancer Center · Duarte, California and 25 other locations · NCT05978141

• Testing new treatments for peripheral T-cell lymphoma

  This study is testing whether adding new drugs, duvelisib or CC-486, to standard chemotherapy can help people with peripheral T-cell lymphoma achieve better treatment results.

  Recruiting at 84 sites Phase 2 Alliance for Clinical Trials in Oncology · Little Rock, Arkansas and 95 other locations · NCT04803201

Related topics

Quick answers

How many Peripheral T-Cell Lymphoma, Not Otherwise Specified clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (8 trials), Mexico (1 trial), Australia (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 3: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →